Ameriprise Financial Inc Burning Rock Biotech LTD Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $1.25 Million - $1.9 Million	-186,162 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $6.65 Million - $12.1 Million	-705,465 Reduced 79.12%	186,162 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $596,902 - $959,442	34,364 Added 4.01%	891,627 $15.9 Million
Q2 2021 Aug 16, 2021	BUY	$26.14 - $37.45 $1.14 Million - $1.63 Million	43,539 Added 5.35%	857,263 $25.2 Million
Q1 2021 May 17, 2021	BUY	$23.5 - $39.58 $857,444 - $1.44 Million	36,487 Added 4.69%	813,724 $21.9 Million
Q4 2020 Feb 12, 2021	BUY	$22.55 - $30.87 $1.2 Million - $1.64 Million	53,276 Added 7.36%	777,237 $18 Million
Q3 2020 Nov 16, 2020	BUY	$19.07 - $29.61 $9.57 Million - $14.9 Million	501,853 Added 225.95%	723,961 $18.1 Million
Q2 2020 Aug 14, 2020	BUY	$23.21 - $31.43 $5.16 Million - $6.98 Million	222,108 New	222,108 $6 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.